Thrombocytopenia and Outcomes in Atrial Fibrillation Patients
Author Information
Author(s): Ding Qiuhua, Xu Wenlin, Chen Yaoyao, Chang Sijie, Zhang Jinhua
Primary Institution: Fujian Maternity and Child Health Hospital, Fujian Medical University, Fuzhou, China
Hypothesis
What is the impact of thrombocytopenia on adverse outcomes in patients with atrial fibrillation?
Conclusion
Thrombocytopenia is linked to a lower risk of ischemic stroke/systemic embolism but a higher risk of major bleeding and all-cause mortality in patients with atrial fibrillation.
Supporting Evidence
- Thrombocytopenia is associated with a lower risk of ischemic stroke/systemic embolism.
- Thrombocytopenia significantly increases the risk of major bleeding.
- Thrombocytopenia is linked to a higher risk of all-cause mortality.
Takeaway
Having low platelets can help prevent some strokes in heart patients, but it can also make them bleed more and increase their chances of dying.
Methodology
A systematic review and meta-analysis of studies on atrial fibrillation patients with thrombocytopenia, using data from PubMed and Web of Science.
Potential Biases
Potential bias due to the inclusion of studies from different regions with varying baseline characteristics.
Limitations
The number of studies and patients included were not enough, leading to a lack of confidence in some outcome indicators.
Participant Demographics
Average age: 72.67 years; 57.3% male.
Statistical Information
P-Value
P<0.01
Confidence Interval
(0.69, 0.91)
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website